RxDoctor Payments Data

Haley Russell, NP

Family · Lynchburg, VANPI 1982072278

Payments from drug & device makers

What this record shows

Medtronic accounts for 76.2% of it on its own, with 11 other manufacturers making up the rest. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,306in general payments, 2019–2025

Across 120 payments — averaging $110.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Impulse Dynamics (USA) Inc.$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$421
  • Cvrx, Inc.$264
  • Atricure, Inc.$213
  • Boston Scientific$212
  • plus $536 from 6 others

What the payments were for

  • Travel & lodging$6,83851%
  • Food & beverage$6,46849%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,306 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$43,657
Medicare patients
350
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban303$226,849
XareltoRivaroxaban75$49,924
EntrestoSacubitril/Valsartan45$29,263
Repatha SureclickEvolocumab13$11,741
FarxigaDapagliflozin Propanediol13$7,405
Dabigatran EtexilateDabigatran Etexilate Mesylate22$4,508
Flecainide Acetate35$2,673
Metoprolol Succinate137$1,352
Amiodarone Hcl106$974
SotalolSotalol Hcl50$752
Losartan Potassium44$433
Potassium Chloride36$388
Metoprolol Tartrate111$346
Atorvastatin Calcium33$312
Carvedilol48$270

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$72$29,26345 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.

Other family in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →